Nestlé India has officially refuted a news report from Moneycontrol.com alleging legal action by FSSAI concerning its baby formula products, NAN EXCELLA PRO & LACTOGEN PRO. The company stated that the products and their labels were approved by FSSAI’s expert committee and confirmed that all products are compliant with applicable regulations and scientific literature, aiming to allay investor concerns.
Nestlé India Addresses Product Compliance News
In response to a recent news item published on Moneycontrol.com on September 18, 2026, Nestlé India Limited has issued a clarification regarding alleged legal action by the FSSAI concerning its baby formula products. The company firmly stated that the news item, which quoted “FSSAI initiates legal action against Nestle India on baby formula, shares fall 2%”, is factually incorrect.
Product Compliance and FSSAI Approval
Nestlé India has confirmed that its products, specifically NAN EXCELLA PRO & LACTOGEN PRO, are fully compliant with all applicable regulations. The company emphasized that these products and their labels received prior approval from the expert committee of the FSSAI. In response to the notice mentioned, Nestlé India has submitted a detailed response to the authorities, providing scientific literature to support the factual nature of its label statements.
Commitment to Regulations and Consumer Awareness
The company reaffirmed its adherence to all regulations, including all norms and label declarations as per applicable laws. Nestlé India stated its commitment to continuing to work closely with and support FSSAI in its efforts towards consumer awareness. The company indicated that no negotiations or events of the nature implied in the news were taking place, and it has not withheld any material information that could explain trading movements, having made all necessary disclosures in a timely and accurate manner.
Impact on Company
Nestlé India has stated that the material impact of this article on the Company is None.
Source: BSE
